Skip to content

Survival and Quality of Life After Liver Transplantation in Patients Aged 65 and Over

Survival and Quality of Life After Liver Transplantation in Patients Aged 65 and Over

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04754503
Acronym
LT 65+
Enrollment
125
Registered
2021-02-15
Start date
2021-04-09
Completion date
2025-04-30
Last updated
2023-01-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Patients Suitable for a Liver Transplant

Keywords

liver transplant

Brief summary

The main objective of this non-interventional, single-center study is to assess survival and associated factors at 1 year in patients aged 65 and over who received liver transplantation

Detailed description

The expected benefits of this study are to identify the preoperative risk factors of mortality from liver transplant failure in patients aged 65 and over (90-day mortality and 1 and 3-year survival) will allow better selection. candidates for this age group. In the current context of organ shortage, this study should make it possible to reduce the number of risky transplants and thus improve the allocation of grafts.Inclusion of patients who meet the inclusion criteria will be carried out during their hospitalization in the surgical department of the hepato-bilary center. Included patients will receive a standardized geriatric assessment in addition to the usual assessment for a liver transplant. The geriatric assessment will be carried out and conducted as follows: geriatric scores and quality of life questionnaires. Two geriatricians will perform the physical examination and blindly estimate each other's probability of survival at 90 days using a Likert scale. Geriatricians will be blinded to hepatic data (reasons for transplantation). The consultation as well as the completion of the questionnaire will be carried out during the pre-transplantation assessment. Survival and quality of life will be assessed at 3 and 12 months post-transplantaion.

Interventions

None listed

Sponsors

Gérond'if
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
65 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Candidates for liver transplantation * Having expressed non-oppostion to his participation in study and documented in his medical file * With social coverage

Exclusion criteria

* Emergency transplant patients * Patient already included in another study * Patient under guardianship or curatorship * Expressing his opposition to participate in the study

Design outcomes

Primary

MeasureTime frame
Assessment of survival and quality of life after liver transplantation according to the quality of life score12 Months

Secondary

MeasureTime frame
Detecting depression in the elderly according the Geriatric Depression Scale (GDS)12 Months

Other

MeasureTime frame
Assessment of patient's level of dependence through an appreciation of instrumental activities of daily living according Lawton scale12 months
Assessment of commorbidity risk according Charlson scoreAt inclusion
Assessment of the emotional, physical and financial burden on a caregiver according Zarit burden scale12 months
Assessment of quality of life according the SF-36 Health Status Questionnaire12 months
Assessment of the degree of patient dependence according Index of Independence in Activities of Daily Living KATZ scale12 Months

Countries

France

Contacts

Primary ContactIsabelle Dufour
isabelle.dufour@gerondif.org+33 (0)185781010
Backup ContactPrisca Lucas, PhD
prisca.lucas@gerondif.org+33 (0)185781010

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026